Telemonitoring modalities in heart failure: comparative effectiveness across the heart failure population—a meta-analysis - Top-Institutions - MDSpire

Telemonitoring modalities in heart failure: comparative effectiveness across the heart failure population—a meta-analysis

  • By

  • Niels T. B. Scholte

  • Pascal R. D. Clephas

  • Eric Boersma

  • Muhammed T. Gürgöze

  • Eelko Ronner

  • Lida Feyz

  • Rudolf A. de Boer

  • Robert M. A. van der Boon

  • Jasper J. Brugts

  • February 10, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Telemedicine

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Digital Health

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Telemedicine Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Digital Health Innovation

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Telemedicine

Original Source(s)

Telemonitoring modalities in heart failure: comparative effectiveness across the heart failure population—a meta-analysis

  • by Niels T. B. Scholte, Pascal R. D. Clephas, Eric Boersma, Muhammed T. Gürgöze, Eelko Ronner, Lida Feyz, Rudolf A. de Boer, Robert M. A. van der Boon, Jasper J. Brugts

  • February 10, 2026

Related Content

Abnormal active myocardial relaxation by dipyridamole stress test in suspected early-stage heart failure with preserved ejection fraction: a retrospective exploratory analysis

Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure

Heterogeneous benefit of early sacubitril/valsartan initiation after PCI in elderly patients with left ventricular dysfunction: myocardial recovery and mid-term cardiovascular outcomes